Septo-Optic Dysplasia (SOD)

Is Stem Cell Treatment for Septo-Optic Dysplasia Effective?

Since 2007, we have been developing comprehensive stem cell treatment protocols for Septo-Optic Dysplasia (SOD) to overcome the limitations of conventional therapies. Septo-optic dysplasia (SOD) – also known as de Morsier syndrome – is a subtype of Optic Nerve Hypoplasia (ONH) and results from underdevelopment of the optic nerve, pituitary gland dysfunction, and absence of the septum pellucidum, which is a midline area of the brain. SOD arises from defects during the embryological development of infants and studies show that ONH maybe be related to gene defects as well as embryo exposure to infections. Read on to see if Septo-optic dysplasia Stem Cell Treatment might be right for your loved one.

Patient Testimonial - Katelyn, Septo-Optic Dysplasia Stem Cell Treatment

Watch more videos

Why our Stem Cell Treatment is Effective for SOD

Since 2007, we have been developing comprehensive stem cell treatment protocols for Septo-Optic Dysplasia (SOD) to overcome the limitations of conventional therapies. In our protocols, stem cells are combined with specialized therapies for SOD that not only focus on helping the patient to cope with their symptoms, but also treat the root cause of the condition by promoting the healing of the optic nerve and other affected brain structures. We believe that our comprehensive treatment approach for SOD gives our patients the best chances for vision improvement, allowing for a better quality of life.

Addressing Damage to the Optic Nerves in Septo-Optic Dysplasia

Septo-Optic Dysplasia (SOD) is a rare congenital condition that involves underdevelopment of the optic nerves, often leading to significant vision impairment or blindness. The optic nerve, responsible for transmitting visual information from the eye to the brain, can be underdeveloped or affected by various factors in SOD, contributing to the challenges patients face.

Potential Contributing Factors in SOD

While the exact causes of optic nerve hypoplasia in SOD are not always clear, it is often associated with disruptions during early brain and ocular development. Other general factors that can exacerbate or mimic optic nerve damage include:

• Compressive Lesions: Growths near the optic nerve, such as pituitary tumors (often seen in SOD due to endocrine dysfunction), can put pressure on the nerve.
• Hereditary or Congenital Conditions: Genetic mutations linked to optic nerve underdevelopment may play a role in SOD.
• Inflammation or Trauma: Inflammation or perinatal injuries may contribute to optic nerve impairment in SOD patients.
• Lifestyle and Environmental Influences: While lifestyle factors do not cause SOD itself, environmental influences during pregnancy could potentially impact fetal development, including the optic nerves.

Identifying Signs of Optic Nerve Damage in SOD

Emerging research into stem cell therapy offers a promising avenue for addressing optic nerve damage in conditions like Septo-Optic Dysplasia. Stem cells have the potential to regenerate damaged tissues and improve the function of underdeveloped optic nerves. Although still in experimental stages, advancements in stem cell treatment may revolutionize care for SOD patients, providing new hope for restoring vision and enhancing quality of life.

Identifying the Signs of Damage to the Optic Nerve

While the signs of optic nerve damage can differ, they frequently consist of:

• flickering or flashing lights when the eyes are moved
• persistent vision loss in one or both eyes
• either gradual or abrupt loss of vision
• Diminished peripheral vision
• Pain within the eye, in the eye socket, or on the face (a common sign of optic neuritis)
• reduced clarity of vision
• Diminished ability to perceive color
• unusual reactions of the pupils to light
• Variations in the optic disc’s appearance

Stem cell therapy has the potential to significantly change the optic nerve damage treatment landscape and provide hope to those afflicted by this difficult condition as research and clinical trials progress.

Possible Improvements after Stem Cell Therapy for Septo-Optic Dysplasia (SOD)

How Stem Cell Therapy Improves Symptoms of Retinal or Optic Nerve Disorders

Stem cells are “pluripotent” cells, meaning they can differentiate into various types of cells and regenerate themselves. They can develop into ectodermal cells (e.g., skin and certain neurological structures), mesodermal cells (e.g., bones, cartilage, and blood cells), or endodermal cells (e.g., those that form internal organs). When injected into the body, donor stem cells can signal the body’s own stem cells to differentiate and replace damaged tissues, such as the retina or optic nerve, which are affected by various ophthalmological disorders. Stem cell therapy has emerged as a promising approach for treating or improving vision-related symptoms caused by retinal or optic nerve degeneration, offering patients a chance at an improved quality of life. Beyond their self-renewing and tissue-replacing capabilities, studies involving stem cell treatments for retinal and optic nerve atrophy have revealed additional benefits, including:

Potential Benefits of Stem Cell Therapy for Septo-Optic Dysplasia (SOD)

1. Replacing and Repairing Underdeveloped Optic Cells: Stem cells can differentiate into specific cell types, including retinal cells and optic neurons, offering the potential to replace underdeveloped or damaged tissues commonly associated with Septo-Optic Dysplasia. This ability to convert into functional optic cells could address the core deficits in the optic nerve and retinal structures seen in SOD.
2. Enhancing Neurotrophic Factor Production: Stem cells can increase the production of neurotrophic factors, such as glial cell-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF). These substances play a critical role in promoting the growth, repair, and differentiation of neural cells, potentially supporting the development and function of optic nerve pathways in SOD patients.
3. Modulating the Immune System and Reducing Inflammation: Stem cells produce antioxidants and other substances that reduce neurodestructive inflammation. By modulating the immune response, they can counteract the atrophic processes and oxidative stress that may further impair optic nerve function in SOD.
4. Preventing Cell Death: Stem cells release factors that inhibit apoptosis (programmed cell death), protecting existing retinal and optic nerve cells from premature death. This protective mechanism ensures that damaged cells remain viable long enough to be repaired or replaced by stem cells, offering hope for improved outcomes in SOD.

This approach highlights the multifaceted potential of stem cell therapy to address the unique challenges posed by Septo-Optic Dysplasia, providing a foundation for future advancements in treatment and care.

Benefits of Stem Cell Therapy in Optic Nerve Atrophy and Retinal Disorders

The purpose of our stem cell treatment for optic nerve hypoplasia/septo-optic dysplasia is to restore neurological function in the brain area and in the optical nerve. Various kinds of improvement are possible after our comprehensive treatment. Past patients have experienced the following improvements*:

• Sharpened visual acuity
• Enhanced light perception
• Enlarged visual field
• Brighter night vision
• Reduced nystagmus
• Improved strabismus
• Improved hormonal deficiencies
• Decreased autistic symptoms

Our Treatment Program in Details

Patient Testimonial - Ireland Kidd, Septo-Optic Dysplasia Stem Cell Treatment

Watch more videos

Medically reviewed by

Dr. Dina Mohyeldeen

Physician & Medical Researcher

Dr. Dina M. is a physician with particular interest in researching advancements in treating different incurable conditions. Her fields of interest include cancers, neurological, and psychiatric conditions given their difficult diagnoses and ever-evolving treatment modalities.

LinkedInResearchGate

Medical References

1. 1.Labrador-Velandia S, Alonso-Alonso ML, Alvarez-Sanchez S, González-Zamora J, Carretero-Barrio I, Pastor JC, et al. Mesenchymal stem cell therapy in retinal and optic nerve diseases: An update of clinical trials. World Journal of Stem Cells. 2016;8(11):376-83. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120242/
2. 2.Weiss JN, Levy S. Stem Cell Ophthalmology Treatment Study (SCOTS): bone marrow derived stem cells in the treatment of Dominant Optic Atrophy. Stem Cell Investigation. 2019;6:41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6987313/
3. 3.Mead B, Berry M, Logan A, Scott RA, Leadbeater W, Scheven BA. Stem cell treatment of degenerative eye disease. Stem Cell Research. 2015;14(3):243-57. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434205/
4. 4.Coco-Martin RM, Pastor-Idoate S, Pastor JC. Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges. Pharmaceutics. 2021;13(6). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230855/
5. 5.Ahmad SS, Kanukollu VM. Optic Atrophy. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. https://www.ncbi.nlm.nih.gov/books/NBK559130/
6. 6.Ludwig PE, Freeman SC, Janot AC. Novel stem cell and gene therapy in diabetic retinopathy, age-related macular degeneration, and retinitis pigmentosa. International Journal of Retina and Vitreous. 2019;5(1):7. https://journalretinavitreous.biomedcentral.com/articles/10.1186/s40942-019-0158-y
7. 7.Luo X, He L, Li J, Cheng H. The role of stem cell therapy in optic nerve regeneration: Current perspectives. Neuroscience Letters. 2020;735:135213. https://doi.org/10.1016/j.neulet.2020.135213
8. 8.Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal progenitor cells from human embryonic stem cells. PNAS. 2006;103(34):12769-74. https://www.pnas.org/content/103/34/12769
9. 9.Johnson TV, Bull ND, Martin KR. Identification of barriers to retinal engraftment of transplanted stem cells. Investigative Ophthalmology & Visual Science. 2010;51(2):960-70. https://iovs.arvojournals.org/article.aspx?articleid=2126415
10. 10.Traboulsi EI, Iacovelli J, Weh E, Fine HF. Optic Nerve Hypoplasia and Septo-Optic Dysplasia. In: Traboulsi EI, editor. Genetic Diseases of the Eye. 2nd ed. Oxford University Press; 2012. p. 571-82. https://oxfordmedicine.com/view/10.1093/med/9780195326147.001.0001/med-9780195326147